We have developed a new universal influenza B vaccination strategy based on inactivated influenza B viruses displaying mosaic hemagglutinins (mHAs). Recombinant mHA viruses were constructed by ...
(NYSEA:IBIO) today reported financial results for the fiscal first quarter ended September 30, 2024 and provided a corporate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback